|
⚲
|
| Keyboard |
| Provectus Biopharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0000315545 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0000315545] | |
| 10-Q | [0000315545] | |
| 3 | [0000315545] | |
| 4 | [0000315545] | |
| 8-K | [0000315545] | |
| D | [0000315545] | |
| SC 13D | [0000315545] | |
| SC 13G | [0000315545] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-03-25 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-03-20 | Option exercise | 49,067 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
Series D-1 Convertible Preferred Stock · derivative
|
2026-03-20 | Option exercise | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-03-12 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-03-05 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-02-26 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-02-20 | Option exercise | 47,180 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
Series D-1 Convertible Preferred Stock · derivative
|
2026-02-20 | Option exercise | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-02-19 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-02-12 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
Series D-1 Convertible Preferred Stock · derivative
|
2026-02-09 | Buy | 34,940 | $2.86 | 99,928 |
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-02-05 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
Series D-1 Convertible Preferred Stock · derivative
|
2026-01-30 | Option exercise | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-01-30 | Option exercise | 37,744 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-01-28 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2026-01-16 | Option exercise | 37,744 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
Series D-1 Convertible Preferred Stock · derivative
|
2026-01-16 | Option exercise | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2025-12-11 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2025-12-05 | Grant | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Unsecured Convertible Promissory Note · derivative
|
2025-11-26 | Grant | $0.00 | ||
| showing 20 of 200 most recent transactions | |||||